Beclin-1 is a key regulatory factor in the autophagy process, and research advancements regarding its role in the tumor immune microenvironment, immunotherapy, and drug sensitivity indicate its potential application value in cancer treatment (333, 334). The gene discussed is BECN1; the disease is cancer.